Blue Eye Soft Announces Commodity Designation and FDA Acknowledgement of BLUEDOCAITM — an AI-driven Medical Imaging Clinical Decision Tool
Emily Wilson2020-07-20T23:00:26+00:00FDA evaluating a Software as a Medical Device (SaMD) to aid in the triage and diagnosis of COVID-19 Blue Eye Soft, an innovative IT-solutions and software development company, announced that it has received acknowledgment from the U.S. Food and Drug Administration (FDA) of its Pre-Submission package for its proprietary artificial [...]